Skip to main content
. 2021 Dec 1;8:782451. doi: 10.3389/fcvm.2021.782451

Table 4.

Current exosomes engineering techniques for Af treatments.

Exosomes engineering technologies Pros Cons
Encapsulate cargoes by sucrose gradient ultracentrifugation Protect drugs from degradation, enhance drugs stability, bioavailability and effect This protocol can only be used for hydrophobic drugs
Encapsulation cargoes through incubation, freeze-thaw cycles, sonication, and extrusion Allows loading of both hydrophilic and hydrophobic drugs Causes exosomal bilayer disruption
EV-imitating structure (liposomes) Targeting, stable structure and contents Physiochemical instability
Can form unwanted degradants
Fusing cardiomyocyte-specific binding peptide to the exosomes (Cardiac homing peptide) Enhance exosomes targeting Displays only protein loading
Manipulation of the loading mechanism to selectively load cargoes into the exosomes (protein loading in exosomes based on integration of light sensitive reversible proteins interaction module) Enhance exosomes targeting
Controllable mechanism of loading
Displays only protein loading
Transfection of a gene encoding exosome-targeting proteins into parent cells. Enhance production efficiency, specific packaging, and delivery to target cells Displays only protein loading
Heart patches and hydrogels Making exosomes release more sustained with higher bioavailability; enhance exosomes effects with better target The delivery approaches with enhanced retention is unsatisfactory